What's Wrong With Nike Stock?
Axe Cap view
Why Nike's Slump Matters for SA Investors
Nike's lost momentum highlights the danger of complacency even for global brands, a lesson for local investors watching currency and retail sectors.
Nike's 79% drop from its peak—and 35% over ten years—raises a red flag about taking brand strength for granted. Their cutback on wholesale partners allowed competitors like Hoka to eat into market share, showing innovation gaps and strategic errors. While the new CEO’s attempt at rebuilding relationships and a 4% rise in wholesale sales in fiscal 2026 are encouraging, the market turnaround is still fragile. For South African investors, the Nike story underlines the risks in consumer-facing companies and the retail chains we follow closely, such as Woolworths and Shoprite. Both face similar pressures from changing consumer patterns and global supply chain issues, worsened by a volatile rand. The USD/ZAR remains crucial here; a weak rand add costs to imported goods, squeezing margins. Investors should be cautious of local retailers' earnings in the near term. this is just our opinion and not financial advice
Avoid aggressive buys in retailers like Woolworths and Shoprite until there’s clearer evidence demand is stabilizing and rand volatility easing. Watch USD/ZAR for signs of currency relief before increasing exposure.
- USD/ZAR
- Woolworths
- Shoprite
- Rand weakening further, increasing import costs
- Consumer demand faltering due to economic pressures
7/10
Nike, the world's largest athletic apparel company, has seen its stock decline 79% from its all-time high and 35% over the past decade due to management missteps including cutting wholesale partnerships and over-reliance on legacy franchises. This allowed competitors like Hoka and Brooks to gain market share. Under new leadership, Nike is rebuilding wholesale relationships and focusing on innovation, with some positive signs emerging including a 4% wholesale increase in fiscal 2026, though a full turnaround remains uncertain.
Our take is based on reporting first published by The Motley Fool.
More stories like this
- Intapp Chief Product Officer Thad Jampol Sells 25,000 Shares
- BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
- Tim Cook Grew Apple From a $350 Billion Company Into a Multi-Trillion-Dollar Giant Over Nearly 15 Years as CEO. Can John Ternus' Product-First Approach Extend That Compounding?